1. Cost-of-Illness Studies

   • Michael Drummond

   Guest Editorial 13 November 2012 Pages: 1 - 4

2. The Cost of Migraine

   • Peter J. Davey
   • Stephen R. Leeder

   Guest Editorial 13 November 2012 Pages: 5 - 7

3. Quality of Life, Health Status and Clinical Drug Research

   • Supornchai Kongpatanakul
   • Brian L. Strom

   Leading Article 13 November 2012 Pages: 8 - 14

4. Pharmacoeconomic Consequences of Measurement and Modification of Hospital Drug Use

   • Lisa L. Ioannides-Demos
   • George M. Eckert
   • Allan J. McLean

   Review Article 13 November 2012 Pages: 15 - 33

5. Cost-Effectiveness of Drug Therapy for Hypercholesterolaemia

   • David Thompson
   • Gerry Oster

   Review Article 13 November 2012 Pages: 34 - 42

6. Quality-of-Life Assessment in Respiratory Disease

   • Michael E. Hyland

   Review Article 13 November 2012 Pages: 43 - 53

7. Assessing the Responsiveness of a Quality-of-Life Instrument and the Measurement of Symptom Severity in Essential Hypertension

   • Margaret C. Reilly
   • Arthur S. Zbrozek

   Original Research Article 13 November 2012 Pages: 54 - 66

8. Healthcare Resource and Lost Labour Costs of Migraine Headache in the US

   • Jane T. Osterhaus
   • Donna L. Gutterman
   • John R. Plachetka

   Original Research Article 13 November 2012 Pages: 67 - 76

9. Comparison of Prescribing Habits of General Practitioners in The Netherlands versus England and Wales

   • F. M. Hull
   • R. F. Westerman
   • R. Jonkers

   Original Research Article 13 November 2012 Pages: 77 - 86

10. Oral Ciprofloxacin versus Intravenous Antibiotics

    • Selwyn D. R. Lang

    Current Comment 13 November 2012 Pages: 87 - 88